How does Sitagliptin interact with anti-inflammatory therapies in diabetes, and does it provide synergistic benefits for reducing chronic inflammation?
Sunil JoshiExplorer
How does Sitagliptin interact with anti-inflammatory therapies in diabetes?
Share
Sitagliptin, a DPP-4 inhibitor used in type 2 diabetes, does not have proven synergistic anti-inflammatory effects when combined with anti-inflammatory therapies.